Insuline Medical Total Asset vs. Revenue
| INSL Stock | ILS 196.00 20.90 9.64% |
For Insuline Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Insuline Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Insuline Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Insuline Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Insuline Medical over time as well as its relative position and ranking within its peers.
Insuline |
Insuline Medical Revenue vs. Total Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Insuline Medical's current stock value. Our valuation model uses many indicators to compare Insuline Medical value to that of its competitors to determine the firm's financial worth. Insuline Medical is currently regarded as number one stock in total asset category among its peers. It also is considered the number one company in revenue category among its peers totaling about 0.03 of Revenue per Total Asset. The ratio of Total Asset to Revenue for Insuline Medical is roughly 39.50 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Insuline Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Insuline Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Insuline Revenue vs. Total Asset
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Insuline Medical |
| = | 1.58 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Insuline Medical |
| = | 40 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Insuline Revenue vs Competition
Insuline Medical is considered the number one company in revenue category among its peers. Market size based on revenue of Medical Devices industry is currently estimated at about 1.21 Billion. Insuline Medical adds roughly 40,000 in revenue claiming only tiny portion of all equities under Medical Devices industry.
Insuline Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Insuline Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Insuline Medical will eventually generate negative long term returns. The profitability progress is the general direction of Insuline Medical's change in net profit over the period of time. It can combine multiple indicators of Insuline Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel. Insuline Medical is traded on Tel Aviv Stock Exchange in Israel.
Insuline Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Insuline Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Insuline Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Insuline Medical's important profitability drivers and their relationship over time.
Use Insuline Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Insuline Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insuline Medical will appreciate offsetting losses from the drop in the long position's value.Insuline Medical Pair Trading
Insuline Medical Pair Trading Analysis
The ability to find closely correlated positions to Insuline Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Insuline Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Insuline Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Insuline Medical to buy it.
The correlation of Insuline Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Insuline Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Insuline Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Insuline Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Insuline Medical position
In addition to having Insuline Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Defence Thematic Idea Now
Aggressive Defence
Macroaxis small cap, aggressive-outlook picks designed for investors that are willing to accept higher levels of risk to hedge exposure to above-average market volatility. The Aggressive Defence theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Defence Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Insuline Stock
To fully project Insuline Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Insuline Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Insuline Medical's income statement, its balance sheet, and the statement of cash flows.